Atm and c-Abl cooperate in the response to genotoxic stress during nervous system development

Heather L Miller1, Youngsoo Lee, Jingfeng Zhao

  • 1Department of Genetics, St. Jude Children's Research Hospital, 332N Lauderdale, Memphis, TN 38105, USA.

Insights

The ATM kinase and c-Abl proto-oncogene are crucial for mouse development and neural integrity. Genetic inactivation revealed their essential roles in preventing midgestational lethality and neurodevelopmental abnormalities.

Area of Science:

  • Genetics
  • Molecular Biology
  • Developmental Biology

Background:

  • The ATM kinase targets the c-Abl proto-oncogene following DNA double-strand breaks.
  • The precise physiological roles of ATM and c-Abl in development remain unclear.

Purpose of the Study:

  • To investigate the functions of c-Abl and ATM during mouse development.
  • To understand the interplay between c-Abl and ATM signaling pathways.

Main Methods:

  • Generation of mice with combined c-Abl and Atm mutant alleles.
  • Analysis of developmental outcomes and neurodevelopmental abnormalities in mutant mice.

Main Results:

  • Dual inactivation of Atm and c-Abl typically led to midgestational lethality.
  • Mice with three mutant alleles (c-Abl(-/-)Atm(+/-) or c-Abl(+/-)Atm(-/-)) were viable but showed increased susceptibility to neurodevelopmental issues after genotoxic stress.

Conclusions:

  • These findings establish a genetic link between ATM and c-Abl signaling pathways.
  • The study highlights a significant interrelationship between ATM and c-Abl in neural development.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...